Home » Instruments and Tools

Instruments and Tools

Instruments and Tools

Click für Deutsch
Click zur deutschen Seite,

In this section, you find a wide range of Instruments and Tools, Complete LC Sytems, Components and Fittings

  1. Low Cost HPLC & UPLC Systems
  2. SFE & SFC Instruments & Plants
  3. Autosampler
  4. LC-Pumps
  5. LC Detectors
  6. LC Software & Controllers
  7. Fraction Collectors
  8. LC Columns & Frits
  9. LC Cartridges & Frits
  10. Flanshes & Adapters
  11. LC Valves
  12. Fittings
  13. Tubings & Capillaries

Instruments and Tools for the life sciences

We in the life sciences can only grow through innovation. Innovation creates and needs unique instruments and tools to create unique problem solutions and methods.

Technology companies are either.

  1. Financially driven. Or
  2. Technology-driven

Financially driven companies are owned and controlled by finance professionals (hedge funds, private equity, venture capitalists). Their prime goal is to increase the profitability and capital gains of the investments.

In the last few years, the hunger to earn more money has increased substantially. And so gradually the idea evolved to procure start-ups and technology producing SMEs.  With large sums of capital, such companies have to be quickly merged with similar enterprises to soon bring them into an IPO  so as to maximise the return of investments. This format is popular with Universities and learned institution. Most bystanders are ready to contribute some knowledge provided they are invited to participate in a technical advisory board. For the investors, it is a convenient form to transfer taxpayer-financed know-how practically free of charge. The winners with this business model are those who put together the deal. Those players make sure they have the lowest risks and the highest gains.

The technology-driven ventures comprise technical people that create and build their technology.  Speed of growth of such venture depends on timing, market demand and size. If large masses of potential buyers find the offered technology cool and affordable they may quickly have many buyers. In such cases, the banks are interested to finance the growth through credits. Every tech freak thinks his creation will be a world leader. However, statistics prove that less than 1% is highly successful. Thus it makes sense to build a boot string organisation and family enterprise. Many people don’t have the tenacity and skills to build such organisations. The majority loses interest in their technology and attend business schools to finish of as manager in a large multinational company.  A minority develops an entrepreneurial mind.  A mind that is curious and permanently searches for business opportunities that can be financed and controlled without external help. Some of the ventures are successful and some are flops.  The owner can live with such circumstance because he controls his entities and equity.  He will stay and treasure his venture(s) until he has enough.

Greed is slowing down progress

Mergers and Acquisition are preferred to build large corporate constructs. Preferred by governments and the finance industry.  In the age of robotics large construct don’t employ many people. We are moving into a world where only a few people work. Unfortunately, those who promote the economic model don’t know how to finance it and keep the workless citizen happy.

We already have a highly educated scientist that was retired at 48 years fo age and gradually drifted into poverty. They certainly don’t think this a sustainable business model.

M & A is money and power-driven.  The power is used to reduce cost. The largest cost is in research. Research in life sciences is discovery, a process of serendipity, a high-risk process.  Those with power will have rational reasons to eliminate research.  It is imaginable that universities are appointed to conduct research or that those companies that have gone this way will merge with companies that still conduct research.  In any case there are many possibilities but the overall picture is rather depressing.

The public believes that tax-funded research should improve the well-being and health of the public. However, this is not happening because research in Universities is fundamental research  will only happen when new independent healthcare companies and industries emerge . Unfortunately, this is not the case. On the contrary, we are producing more qualified specialists but not enough productive jobs for these specialists. That means the state must create jobs and finance them with taxpayers’ money.

In the post-war years, there were many people with unique ideas. They decided to realize their vision with financial support from family and friends. They were driven by technology interests and they knew that effective and inexpensive products and services will be procured. It was these people who provided unique tools to the life science and health industries until around the year 2000, thus creating global growth and prosperity.

The Future path to progress.

Economists argue that real progress is only possible through competition. This means that better products displace lower quality and less developed ones. Indeed, competition leads to the continuous improvement of everything, which is particularly important in young life and health sciences.

A pharmaceutical company cannot grow unless it develops better and more competitive drugs, vaccines, diagnostics, and medical devices. Tools are an important component in this development process. In the past 10 years, the simplification of the existing processes and tools has been pushed forward. In the western world, technology-driven instrument and tool suppliers were prevented from accessing large hedge fund-controlled life science and health companies. In the past, many technologies driven companies supplied unique tools to create patent extensions by up to two years.   This meant billions in additional business income. Ignorance has eliminated this path.

Today the pharmaceutical industry is moving in all possible directions and nobody knows where the journey is going. The pharmaceutical industry is segmenting its markets into 1. Large market therapeutics, 2. therapeutics for rare(orphan) diseases and therapeutics for tropical diseases. There are around 1000 diseases in segment 1, around 7000 in segment 2, and around 25 in segment 3.

With today’s high costs it is difficult to finance the development of therapeutics for patients suffering from rare diseases. They have little chance of a cure. One day the public will discover the reality and react to it. Hedge funds should wake up and create now progress in the health and life sciences!

Fortunately, many new pharmaceuticals and other industries are evolving in Asia and emerging markets. Many emerging market governments are reluctant to partner with large finance-driven companies. They promote the local production of generic products with new financial and business models. They are also looking for instrument and tool developers who may be able to help improving productivity or to find sales partners abroad. Using new production technologies will also help to internationalize the business faster.

Creative, technology-driven Instruments and Tools Developers

Most are small private companies who put a lot of passion for continuously developing their technologies. They enjoy working with other like-minded people who have different professional skills.

In the late 1990s, we decided to work with other private companies that produce high-quality components. We saw our business in working together with creative drug discoverers and developers.  Both parties had ideas and ambitions to create together new processes that produced unique therapeutics and diagnostics. It was our job to organize the individual components from our partners and to discuss with them possibilities of productivity enhancement and creating more uniqueness and to assign ownership. Finally, we must create the final problem solution and branded it Consensus.

How can you benefit from the Consensus philosophy?

What we as partners enjoy is developing new, intelligent, and sustainable technology/instruments/devices together with all partners. It is a give and takes strategy. All those carry the risk and share the results. This way we focus on technical competency and skill to address complex customer problems and we drive the industry forward.

Consensus means

  1. In accordance (We act in accordance with international rules and regulations and with the joy of problem-solving technology from our friends and partners. Like
  2. Agreement (The various parties have reached an agreement to support each other and create high-quality products for customers.)
  3. Compliance / Compliance (All technologies/contracts have been drawn up in accordance with the same understanding of product quality or applicable law.
  4. Conformity (All components in our tools conform to definition or laws for quality or uniqueness.)
  5. Match (We will always try to reconcile all needs and ambitions between our customers, partners, and ourselves)

Every technology-driven company has expertise in one or two fields. However, to stay independent and to survive it must collaborate with a friendly partner and to sell expertise from such partners. For 25 Years we work together with many independent, highly specialized tools creating partners to create together tailored solutions under the brand name ConsensusTM XYZ. We all agree that

  • Our tools must be price competitively
  • Must be better and more advanced than mainstream competitors
  • Our approach with clients must be flexible
  • We offer quick, reliable, and competent support and service
  • As technically driven partners we communicate data, in a frank and open manner.

Our Client partners are highly skilled Chromatographers

They understand how to use and maintain their instruments and tools. In finance-driven organizations, everything must be exchangeable. Contracts are established with the equipment suppliers to maintain the Instruments. Chromatographers are tool users only. However, for us, it is important that our clients have a high degree of freedom to choose those tools so they will be sure that the instrument will improve productivity. Equipment that is cared for by its users is more cost-effective, they last longer, and the user’s job security is much better because he can react to a problem quickly. As a family owned specialist and supplier of price-competitive tools we care unable to set up in every town a sales/service office. However, the speed of solving problems is the essence of service. We are developing technologies to on-line assist our clients in every corner of the globe.  Furthermore, we guide our clients to perform easy equipment maintenance and repair. Since our beginning, we have a growing number of loyal clients. They appreciate our attention to details including quick and uncomplicated service. Thanks for your support

Willi Glettig Proprietor